cytosine has been researched along with Respiratory Tract Infections in 41 studies
Respiratory Tract Infections: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aurintricarboxylic acid (ATA) and ethacrynic acid (ECA) have been reported to exhibit antiviral activity against vaccinia virus infections in cell culture by inhibiting early and late gene transcription, respectively." | 7.76 | Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice. ( Hurst, BL; Smee, DF; Wong, MH, 2010) |
| "Aurintricarboxylic acid (ATA) and ethacrynic acid (ECA) have been reported to exhibit antiviral activity against vaccinia virus infections in cell culture by inhibiting early and late gene transcription, respectively." | 3.76 | Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice. ( Hurst, BL; Smee, DF; Wong, MH, 2010) |
| "Ribavirin has also been used to treat parainfluenza virus and human metapneumovirus, but data are inconclusive in this setting." | 2.53 | Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. ( Berger, A; Christopeit, M; Hauf, E; Hentrich, M; Heussel, CP; Kalkreuth, J; Klein, M; Kochanek, M; Lehners, N; Mayer, K; Penack, O; Rieger, C; Schalk, E; Silling, G; Vehreschild, M; von Lilienfeld-Toal, M; Weber, T; Wolf, HH, 2016) |
| " This study reviews the published dosing regimens of intralesional cidofovir in the treatment of RRP in order to provide a precedent for those that wish to prescribe it." | 2.49 | Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis. ( Clamp, PJ; Saunders, MW, 2013) |
| "To evaluate the recurrence pattern, the larynx was divided into 10 subsites, and patients were investigated for the frequency of recurrence at the subsites after the operation." | 1.43 | Is recurrent respiratory papillomatosis a manageable or curable disease? ( Baizhumanova, AS; Kim, HT, 2016) |
| "Problem of treatment is the high recurrence of papilloma growth after surgical removal; therefore adjuvant therapy schemes have been established." | 1.39 | Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis. ( Friedrich, G; Graupp, M; Gugatschka, M; Hammer, G; Kiesler, K; Reckenzaun, E, 2013) |
| " Administration should remain below established safe limits of dosing (3 mg/kg) and volume." | 1.39 | Current use of intralesional cidofovir for recurrent respiratory papillomatosis. ( Chadha, NK; Derkay, CS; Froehlich, P; McMurray, JS; Pransky, SM; Rosen, CA; Volsky, PG, 2013) |
| "Early detection of pathogens causing respiratory infections in institutions, isolation, and other preventive precautions are advocated." | 1.37 | An outbreak of adenovirus type 7 in a residential facility for severely disabled children. ( Averbuch, D; Braun, J; Dehtyar, N; Engelhard, D; Ghanaiem, H; Koplewitz, BZ; Mandelboim, M; Wolf, DG; Yatsiv, I, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (14.63) | 29.6817 |
| 2010's | 34 (82.93) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carifi, M | 1 |
| Manickavasagam, J | 1 |
| Wu, K | 1 |
| Bateman, ND | 1 |
| Dikkers, FG | 4 |
| Clamp, PJ | 2 |
| Saunders, MW | 2 |
| Durvasula, VS | 1 |
| Richter, GT | 1 |
| Chirilă, M | 2 |
| Bolboacă, SD | 1 |
| Moore, JE | 1 |
| Garcia, A | 1 |
| Sanyal, S | 1 |
| Saunders, S | 1 |
| Portnoy, JE | 1 |
| Hu, A | 1 |
| Sataloff, RT | 2 |
| Grasso, M | 2 |
| Remacle, M | 4 |
| Bachy, V | 1 |
| Van Der Vorst, S | 1 |
| Lawson, G | 3 |
| Lachiewicz, AM | 1 |
| Cianciolo, R | 1 |
| Miller, MB | 1 |
| Derebail, VK | 1 |
| San Giorgi, MR | 1 |
| Tjon Pian Gi, RE | 3 |
| Murono, S | 2 |
| Nakanishi, Y | 2 |
| Tsuji, A | 2 |
| Endo, K | 2 |
| Kondo, S | 2 |
| Wakisaka, N | 2 |
| Yoshida, H | 1 |
| Yoshizaki, T | 2 |
| Fusconi, M | 1 |
| Greco, A | 1 |
| Gallo, A | 1 |
| Campo, F | 1 |
| Turchetta, R | 1 |
| Pagliuca, G | 1 |
| DE Vincentiis, M | 1 |
| Karatayli-Ozgursoy, S | 1 |
| Bishop, JA | 1 |
| Hillel, A | 1 |
| Akst, L | 1 |
| Best, SR | 1 |
| Kim, HT | 1 |
| Baizhumanova, AS | 1 |
| Zeitels, SM | 1 |
| Lynch, JP | 1 |
| Kajon, AE | 1 |
| von Lilienfeld-Toal, M | 1 |
| Berger, A | 1 |
| Christopeit, M | 1 |
| Hentrich, M | 1 |
| Heussel, CP | 1 |
| Kalkreuth, J | 1 |
| Klein, M | 1 |
| Kochanek, M | 1 |
| Penack, O | 1 |
| Hauf, E | 1 |
| Rieger, C | 1 |
| Silling, G | 1 |
| Vehreschild, M | 1 |
| Weber, T | 1 |
| Wolf, HH | 1 |
| Lehners, N | 1 |
| Schalk, E | 1 |
| Mayer, K | 1 |
| Drejet, S | 1 |
| Halum, S | 1 |
| Brigger, M | 1 |
| Skopelja, E | 1 |
| Parker, NP | 1 |
| Meacham, RK | 1 |
| Thompson, JW | 1 |
| Derkay, C | 1 |
| Smee, DF | 6 |
| Hurst, BL | 1 |
| Wong, MH | 4 |
| Rivière, F | 1 |
| Gille, T | 1 |
| Le Tinier, JY | 1 |
| Gharbi, N | 1 |
| Khalil, A | 1 |
| Wislez, M | 1 |
| Cadranel, J | 1 |
| Ksiazek, J | 1 |
| Prager, JD | 1 |
| Sun, GH | 1 |
| Wood, RE | 1 |
| Arjmand, EM | 1 |
| Wierzbicka, M | 2 |
| Jackowska, J | 2 |
| Bartochowska, A | 1 |
| Józefiak, A | 1 |
| Szyfter, W | 1 |
| Kędzia, W | 1 |
| Ghanaiem, H | 1 |
| Averbuch, D | 1 |
| Koplewitz, BZ | 1 |
| Yatsiv, I | 1 |
| Braun, J | 1 |
| Dehtyar, N | 1 |
| Wolf, DG | 1 |
| Mandelboim, M | 1 |
| Engelhard, D | 1 |
| Gáll, T | 1 |
| Kis, A | 1 |
| Fehér, E | 1 |
| Gergely, L | 1 |
| Szarka, K | 1 |
| Dietz, A | 2 |
| Djukic, V | 1 |
| Eckel, HE | 1 |
| Friedrich, G | 3 |
| Golusinski, W | 2 |
| Hantzakos, A | 2 |
| Rihkanen, H | 1 |
| Russell, A | 1 |
| Ennis, J | 1 |
| Turner, JD | 1 |
| DeFatta, RA | 1 |
| Sataloff, JB | 1 |
| Klaris, GE | 1 |
| Mikolajczak, S | 1 |
| Quante, G | 1 |
| Weissenborn, S | 1 |
| Wafaisade, A | 1 |
| Wieland, U | 1 |
| Lüers, JC | 1 |
| Klussmann, JP | 1 |
| Beutner, D | 1 |
| Graupp, M | 2 |
| Gugatschka, M | 1 |
| Kiesler, K | 1 |
| Reckenzaun, E | 1 |
| Hammer, G | 1 |
| Derkay, CS | 1 |
| Volsky, PG | 1 |
| Rosen, CA | 1 |
| Pransky, SM | 1 |
| McMurray, JS | 1 |
| Chadha, NK | 1 |
| Froehlich, P | 1 |
| Ilmarinen, T | 1 |
| van den Heuvel, ER | 1 |
| Aaltonen, LM | 1 |
| Andersen, J | 1 |
| Brunings, JW | 1 |
| Ferran Vilà, F | 1 |
| de Gier, HH | 1 |
| Horcasitas, R | 1 |
| Koelmel, JC | 1 |
| Lindner, F | 1 |
| Sittel, C | 1 |
| Weichbold, V | 1 |
| Bailey, KW | 4 |
| Beadle, JR | 2 |
| Hostetler, KY | 2 |
| Sidwell, RW | 4 |
| Trahan, J | 1 |
| Aldern, KA | 1 |
| Owens, G | 1 |
| Schriewer, J | 1 |
| Melman, L | 1 |
| Buller, RM | 1 |
| Wong, M | 1 |
| Borgen, HC | 1 |
| Ludwig, H | 1 |
6 reviews available for cytosine and Respiratory Tract Infections
| Article | Year |
|---|---|
Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
Topics: Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedul | 2013 |
Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respir | 2014 |
Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention.
Topics: Adenoviridae; Adenoviridae Infections; Adenovirus Infections, Human; Adult; Antiviral Agents; Child; | 2016 |
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Community-Acquired Infections; Cytosine; | 2016 |
A Systematic Review.
Topics: Adult; Angiogenesis Inhibitors; Antiviral Agents; Bevacizumab; Cidofovir; Cytosine; Humans; Injectio | 2017 |
Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cidofovir; Cytosine; Humans; Injections, Intralesional; Organophosphonates; Papill | 2013 |
35 other studies available for cytosine and Respiratory Tract Infections
| Article | Year |
|---|---|
Use of cidofovir in recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cytosine; Female; Humans; Male; Organophosphonates; Papillomavirus Infections; Res | 2013 |
Treatment of paediatric laryngeal papillomas: web survey of British Association of Paediatric Otolaryngologists.
Topics: Anticarcinogenic Agents; Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Health Ca | 2013 |
Letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Topics: Antiviral Agents; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respiratory Tract | 2013 |
Response to Dikkers letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Topics: Antiviral Agents; Cytosine; Humans; Organophosphonates; Papillomavirus Infections; Respiratory Tract | 2013 |
Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Follow-Up | 2014 |
Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Male; Middle Aged; Organophosphonates; Papill | 2013 |
Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Injections, I | 2014 |
Adenovirus causing fever, upper respiratory infection, and allograft nephritis complicated by persistent asymptomatic viremia.
Topics: Adenoviridae; Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Com | 2014 |
The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors.
Topics: Cytosine; Female; Humans; Male; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Res | 2015 |
Trends in the management of recurrent respiratory papillomatosis in Japan.
Topics: Antiviral Agents; Cidofovir; Cytosine; Debridement; Disease Management; Humans; Japan; Laser Therapy | 2015 |
Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma; Cell Transfor | 2016 |
Is recurrent respiratory papillomatosis a manageable or curable disease?
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chemotherapy, Adjuvant; Child; Cidofovir; Combined Modali | 2016 |
Glottic Cancer: A Metamorphosing Disease.
Topics: Adolescent; Adult; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Cytosine; Diagnostic Error | 2016 |
Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Topics: Adult; Aged; Antiviral Agents; Cidofovir; Cytosine; Female; Human papillomavirus 6; Humans; Injectio | 2016 |
Comparison of cidofovir and the measles, mumps, and rubella vaccine in the treatment of recurrent respiratory papillomatosis.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; Cytosin | 2017 |
Use of cidofovir for treatment of recurrent respiratory papillomatosis.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Humans; Organophosphonates; Papilloma; Recurrence; R | 2009 |
Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice.
Topics: Animals; Antiviral Agents; Aurintricarboxylic Acid; Cell Line; Cidofovir; Cytosine; Ethacrynic Acid; | 2010 |
Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
Topics: Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Infusions, Intravenous; Lung; Middle Aged; Or | 2011 |
Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis.
Topics: Administration, Inhalation; Aerosols; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; | 2011 |
Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Cidofovir; Cohort Studies; Cyto | 2011 |
An outbreak of adenovirus type 7 in a residential facility for severely disabled children.
Topics: Adenoviridae; Adenovirus Infections, Human; Antiviral Agents; Child, Preschool; Cidofovir; Cytosine; | 2011 |
Virological failure of intralesional cidofovir therapy in recurrent respiratory papillomatosis is not associated with genetic or epigenetic changes of HPV11: complete genome comparison of sequential isolates.
Topics: Antiviral Agents; Cidofovir; Cytosine; DNA Methylation; DNA, Viral; Epigenesis, Genetic; Genome, Vir | 2011 |
Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
Topics: Adverse Drug Reaction Reporting Systems; Antiviral Agents; Cidofovir; Cytosine; Injections, Intrales | 2012 |
Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201).
Topics: Adenoviridae; Administration, Intranasal; Animals; Body Weight; Cidofovir; Cytosine; Female; Genetic | 2011 |
Laryngeal papilloma.
Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Humans; Injections, Intralesional; | 2012 |
The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; DNA, Viral; Female; Human papillomavirus 11; Human pap | 2012 |
Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cy | 2013 |
Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
Topics: Antiviral Agents; Chemotherapy, Adjuvant; Cidofovir; Cross-Sectional Studies; Cytosine; Humans; Inje | 2013 |
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Female; Head and Neck Neoplasms; H | 2013 |
Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
Topics: Animals; Antiviral Agents; Body Weight; Brain; Cidofovir; Cytosine; Drug Evaluation, Preclinical; He | 2004 |
Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice.
Topics: Administration, Oral; Animals; Cidofovir; Cytosine; Ectromelia virus; Ectromelia, Infectious; Female | 2007 |
Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
Topics: Animals; Antiviral Agents; Body Weight; Cell Line; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox v | 2000 |
Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cowpox; Cowp | 2000 |
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Blood Gas Monitoring, Transcutaneous; Body We | 2001 |
Equine herpesvirus 1: biological and biophysical comparison of two viruses from different clinical entities.
Topics: Abortion, Veterinary; Animals; Antigens, Viral; Base Sequence; Cell Line; Centrifugation, Density Gr | 1974 |